PATENT CLAIM ANALYSIS

Application Number: 15765310
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "230500"]

Abstract:
The present invention relates to therapeutic combinations of anti-bacterial agents linezolid, bedaquiline and pretomanid, and optionally with pyrazinamide, in a short-course oral dosage regimen for the treatment of tuberculosis.

Claim (Index 2):
The pharmaceutical composition according to  claim 1 , wherein linezolid is at a dosage of 100mg/kg.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.13793
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13942342', '15409911', '15523906', '10844992', '16087161']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7239591511803057
- 35 USC 102 Novelty (BERT): 0.5013573968798224
- Combined Prediction Score: 0.7016989757502574
- Mean Citation Score: 187.943938
- Max Citation Score: 204.82497
- Similarity Product: 140.86299765749575

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test